Newsroom

Press Releases

 

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime

Orlando, Fla. – Jan. 6, 2020 – AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy.  

Read More >

Media Contact

Adrienne Foley
Corporate Communications Manager
[email protected]

Connect with us 24/7